Market Closed -
OTC Markets
01:20:49 29/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.097
USD
|
+13.45%
|
|
+13.45%
|
-86.43%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8.199
|
34.48
|
64.46
|
28.58
|
Enterprise Value (EV)
1 |
7.41
|
34.06
|
66.72
|
34.46
|
P/E ratio
|
-59.5
x
|
-2.92
x
|
-5.79
x
|
-2.57
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.55
x
|
41.7
x
|
52.9
x
|
19.1
x
|
EV / Revenue
|
6.82
x
|
41.2
x
|
54.7
x
|
23
x
|
EV / EBITDA
|
-19.5
x
|
-4.48
x
|
-8.28
x
|
-4.03
x
|
EV / FCF
|
12,21,26,615
x
|
8,89,34,634
x
|
-4,78,11,969
x
|
48,73,19,351
x
|
FCF Yield
|
0%
|
0%
|
-0%
|
0%
|
Price to Book
|
11.5
x
|
6.47
x
|
-37.1
x
|
-4
x
|
Nbr of stocks (in thousands)
|
8,038
|
25,926
|
40,287
|
39,968
|
Reference price
2 |
1.020
|
1.330
|
1.600
|
0.7150
|
Announcement Date
|
22/12/21
|
28/04/22
|
31/03/23
|
17/06/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1.14
|
1.086
|
0.8273
|
1.219
|
1.498
|
EBITDA
1 |
-0.3107
|
-0.3799
|
-7.611
|
-8.062
|
-8.557
|
EBIT
1 |
-0.3109
|
-0.3801
|
-7.74
|
-8.066
|
-8.573
|
Operating Margin
|
-27.28%
|
-35.01%
|
-935.59%
|
-661.77%
|
-572.37%
|
Earnings before Tax (EBT)
1 |
-0.3258
|
-0.2637
|
-8.419
|
-10.05
|
-11.1
|
Net income
1 |
-0.1662
|
-0.1379
|
-7.752
|
-10.72
|
-11.1
|
Net margin
|
-14.58%
|
-12.7%
|
-937.04%
|
-879.89%
|
-741.19%
|
EPS
|
-
|
-0.0172
|
-0.4562
|
-0.2765
|
-0.2778
|
Free Cash Flow
|
-
|
0.0607
|
0.383
|
-1.395
|
0.0707
|
FCF margin
|
-
|
5.59%
|
46.3%
|
-114.49%
|
4.72%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/12/21
|
22/12/21
|
28/04/22
|
31/03/23
|
17/06/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.23
|
-
|
-
|
2.26
|
5.88
|
Net Cash position
1 |
-
|
0.79
|
0.42
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.7287
x
|
-
|
-
|
-0.2806
x
|
-0.6871
x
|
Free Cash Flow
|
-
|
0.06
|
0.38
|
-1.4
|
0.07
|
ROE (net income / shareholders' equity)
|
-
|
-291%
|
-265%
|
-569%
|
253%
|
ROA (Net income/ Total Assets)
|
-
|
-20.1%
|
-98.9%
|
-93.5%
|
-267%
|
Assets
1 |
-
|
0.6869
|
7.834
|
11.47
|
4.154
|
Book Value Per Share
|
-
|
0.0900
|
0.2100
|
-0.0400
|
-0.1800
|
Cash Flow per Share
|
-
|
0.1300
|
0.0100
|
0.0200
|
0
|
Capex
|
-
|
-
|
0.01
|
0.06
|
0.04
|
Capex / Sales
|
-
|
-
|
0.61%
|
4.72%
|
2.37%
|
Announcement Date
|
22/12/21
|
22/12/21
|
28/04/22
|
31/03/23
|
17/06/24
|
|
1st Jan change
|
Capi.
|
---|
| -86.43% | 44.42L | | -4.94% | 2.96TCr | | +49.49% | 998.13Cr | | +34.36% | 440.27Cr | | -42.11% | 219.26Cr | | -9.44% | 160.39Cr | | -28.06% | 124.31Cr | | -42.92% | 98Cr | | +8.65% | 97Cr | | -47.18% | 74Cr |
Medical Software & Technology Services
|